CIULLA THOMAS enters VIRIDIAN THERAPEUTICS, INC.\DE with 762.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/12/2024ACC: 0000950170-24-004264
Officer· Chief Medical Officer
Since Jan 2024
762.00
Baseline shares
100% direct
762.00
Direct ownership
1 position
570K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned762.00
Total
762.00 direct762.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 762.00 | Direct |
| Total | 762.00 | 762.00 direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
270K
Shares owned
N/A
Exercise price
13.76
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
250K
Shares owned
N/A
Exercise price
33.06
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
50K
Shares owned
N/A
Exercise price
28.22
Expiration
—
Exercise window
—
Total
Underlying
570K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 13.76 | — | — | 270K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 33.06 | — | — | 250K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 28.22 | — | — | 50K | N/A |
| Total | 570K | 0.00 | ||||